New Study Shows Complications Rare in Test-tube Fertility Procedures

Life Science Investing News

The Associated Press reported that a new American 12-year study shows that complications are rare for women undergoing test-tube fertility procedures. Most frequently problems happen when drugs are used to stimulate ovaries, but even then fatalities don’t usually arise.

The Associated Press reported that a new American 12-year study shows that complications are rare for women undergoing test-tube fertility procedures. Most frequently problems happen when drugs are used to stimulate ovaries, but even then fatalities don’t usually arise.

As quoted in the market news:

Over-stimulated ovaries occurred in 154 out of every 10,000 pregnancy attempts; rates of other complications were less than 10 per 10,000 attempts. There were 58 deaths reported during the 2000-11 study. The study lacks information on their causes, and with more than 1 million pregnancy attempts involved, the results are reassuring, said Dr. Jennifer Kawwass, an Emory University assistant professor and the lead author.

The study is the first large-scale effort to quantify risks for U.S. patients undergoing these treatments, Kawwass said. Results were published in Tuesday’s Journal of the American Medical Association.

Click here to read the full report from The Associated Press.

The Conversation (0)
×